| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0002400 | Exon-Exon | chr4:144446604-144465125 | chr4:143525451-143543972 | 126 nt | 0.3571 |
| hsa_SMARCA5_0002000 | Exon-Exon | chr4:144446604-144469293 | chr4:143525451-143548140 | 2465 nt | 0.3870 |
| hsa_SMARCA5_0002500 | Exon-Exon | chr4:144447434-144449176 | chr4:143526281-143528023 | 336 nt | 0.3542 |
| hsa_SMARCA5_0002800 | Exon-Exon | chr4:144447434-144449867 | chr4:143526281-143528714 | 312 nt | 0.3750 |
| hsa_SMARCA5_0002900 | Exon-Exon | chr4:144447434-144451679 | chr4:143526281-143530526 | 405 nt | 0.3630 |
| hsa_SMARCA5_0002600 | Exon-Exon | chr4:144447434-144460091 | chr4:143526281-143538938 | 1149 nt | 0.3856 |
| hsa_SMARCA5_0003000 | Exon-Exon | chr4:144447434-144461648 | chr4:143526281-143540495 | 133 nt | 0.4060 |
| hsa_SMARCA5_0002700 | Exon-Exon | chr4:144447434-144464810 | chr4:143526281-143543657 | 1431 nt | 0.3878 |
| hsa_SMARCA5_0003100 | Exon-Exon | chr4:144447434-144465125 | chr4:143526281-143543972 | 120 nt | 0.3667 |
| hsa_SMARCA5_0003200 | Exon-Exon | chr4:144447434-144466736 | chr4:143526281-143545583 | 225 nt | 0.4044 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].